Epidemiology versus scare mongering: The case for the humane interpretation of statistics and breast cancer

Breast Journal

Volumn 6, Issue 5, 2000, Pages 331-334

  Baum, Michael ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CRC   (United Kingdom)

Author keywords

BRCA1 BRCA2; Breast cancer; Epidemiology; Hormone replacement therapy; Oral contraceptives; Risk assessment; Screening

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; FEMALE; GENETIC PREDISPOSITION; HEALTH CARE POLICY; HEALTH EDUCATION; HORMONE SUBSTITUTION; HUMAN; MASS MEDIUM; ORAL CONTRACEPTION; PATIENT COUNSELING; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 0033764908     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2000.20073.x     Document Type: Article

References (10)

1. Putting the risk of breast cancer in perspective
2. Patient's perception of risk and breast cancer awareness
3. Mortality associated with oral contraceptive use: 25 Year follow up of a cohort of 46,000 women from the Royal College of General Practitioner's oral contraceptive study
4. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
5. Genetic counselling for hereditary breast cancer
6. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel P-1 Study
7. Mammography and the politics of randomised controlled trials
8. Efficacy of screening mammography - A meta-analysis
9. Breast cancer screening results in worrying number of false-positive results
10. Mammographically detected ductal carcinoma in situ: Are we overdiagnosing breast cancer?